SS TV -- The pharmaceutical company GlaxoSmithKline plc announced that it will invest LE 500 million in Egypt’s healthcare sector in five years to expand its product portfolio. The company will focus its attention mainly on the manufacturing, employment and advertising areas of its widely accepted products like Sensodyne and Panadol.
